{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:19:30Z","timestamp":1783084770202,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Iron deficiency is a common and clinically relevant comorbidity in heart failure, associated with reduced functional capacity, higher symptom burden, and increased hospitalisation risk. Most evidence on iron deficiency in heart failure originates from hospital-based cohorts, whereas the epidemiology and clinical implications in primary care populations remain poorly described. This study aimed to determine the prevalence of iron deficiency among primary care patients with heart failure in southern Sweden and to examine its association with symptom severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional analysis used baseline data from the Heart Failure in Southern Sweden study, a prospective intervention project conducted at 20 primary health care centres. Adult patients with heart failure across all left ventricular ejection fraction categories were included. Iron deficiency was defined as transferrin saturation\u2009&lt;\u200920%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 466 primary care patients with heart failure were included, of whom 124 (26.7%) had iron deficiency. Symptom severity was higher in patients with iron deficiency: 35.5% were classified as New York Heart Association (NYHA) class III\u2013IV, compared with 18.7% among patients without iron deficiency. Similar findings were observed in the subgroup with left ventricular ejection fraction below 50%, where 25.2% had iron deficiency and 42.6% were classified as NYHA III\u2013IV compared with 18.4% among patients without iron deficiency. In multivariable analysis adjusting for clinically relevant covariates, iron deficiency remained associated with NYHA class III\u2013IV (OR 1.97, 95% CI 1.18\u20133.31,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Iron deficiency is common among patients with heart failure managed in primary care and remained associated with higher symptom burden after adjustment for prespecified covariates. These findings highlight the potential clinical relevance of assessment of iron status in primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT04129658. Registered on 15 October 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06207-8","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:14:50Z","timestamp":1783070090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Iron deficiency in primary care patients with heart failure: a cross-sectional study of the heart failure in Southern Sweden (HISS) cohort"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9498-1573","authenticated-orcid":false,"given":"Fredrik","family":"Vinge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moa","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gustav","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica Milos","family":"Nymberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"6207_CR1","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/cfr.2023.05","volume":"9","author":"B Shahim","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH. Global Public Health Burden of Heart Failure: An Updated Review. Card Fail Rev. 2023;9:e11.","journal-title":"Card Fail Rev"},{"issue":"7","key":"6207_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/ehjqcco\/qcaf054","volume":"11","author":"S Yan","year":"2025","unstructured":"Yan S, Deng P, Chai K, Wang S, Hu K, Yang J, et al. Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study. Eur Heart J Qual Care Clin Outcomes. 2025;11(7):1144\u201354.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"17","key":"6207_CR3","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/heartjnl-2021-320131","volume":"108","author":"S Emmons-Bell","year":"2022","unstructured":"Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022;108(17):1351\u201360.","journal-title":"Heart"},{"issue":"1","key":"6207_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S von Haehling","year":"2019","unstructured":"von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron Deficiency in Heart Failure: An Overview. JACC Heart Fail. 2019;7(1):36\u201346.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"6207_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","volume":"1","author":"JG Cleland","year":"2016","unstructured":"Cleland JG, Zhang J, Pellicori P, Dicken B, Dierckx R, Shoaib A, et al. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure. JAMA Cardiol. 2016;1(5):539\u201347.","journal-title":"JAMA Cardiol"},{"issue":"4","key":"6207_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","volume":"79","author":"G Masini","year":"2022","unstructured":"Masini G, Graham FJ, Pellicori P, Cleland JGF, Cuthbert JJ, Kazmi S, et al. Criteria for Iron Deficiency in Patients With Heart Failure. J Am Coll Cardiol. 2022;79(4):341\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"6207_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","volume":"71","author":"BML Rocha","year":"2018","unstructured":"Rocha BML, Cunha GJL, Menezes Falcao LF. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol. 2018;71(7):782\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"6207_CR8","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436\u201348.","journal-title":"N Engl J Med"},{"issue":"10369","key":"6207_CR9","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 2022;400(10369):2199\u2013209.","journal-title":"Lancet"},{"issue":"4","key":"6207_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ejhf.2810","volume":"25","author":"FJ Graham","year":"2023","unstructured":"Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JGF. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. Eur J Heart Fail. 2023;25(4):528\u201337.","journal-title":"Eur J Heart Fail"},{"issue":"48","key":"6207_CR11","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","volume":"44","author":"P Ponikowski","year":"2023","unstructured":"Ponikowski P, Mentz RJ, Hernandez AF, Butler J, Khan MS, van Veldhuisen DJ, et al. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. Eur Heart J. 2023;44(48):5077\u201391.","journal-title":"Eur Heart J"},{"issue":"37","key":"6207_CR12","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J"},{"issue":"19","key":"6207_CR13","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317(19):1958\u201366.","journal-title":"JAMA"},{"issue":"10","key":"6207_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ajh.24820","volume":"92","author":"MD Cappellini","year":"2017","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068\u201378.","journal-title":"Am J Hematol"},{"issue":"12","key":"6207_CR15","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ejhf.1305","volume":"20","author":"T McDonagh","year":"2018","unstructured":"McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018;20(12):1664\u201372.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"6207_CR16","doi-asserted-by":"publisher","first-page":"102662","DOI":"10.1016\/j.jchf.2025.102662","volume":"13","author":"F Lindberg","year":"2025","unstructured":"Lindberg F, Cabrera CC, Benson L, Lofstrom U, Lindmark K, Hage C, et al. Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific Outcomes. JACC Heart Fail. 2025;13(11):102662.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"6207_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165(4):575\u201382. e3.","journal-title":"Am Heart J"},{"issue":"2","key":"6207_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.124.068883","volume":"150","author":"M Packer","year":"2024","unstructured":"Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, et al. Redefining Iron Deficiency in Patients With Chronic Heart Failure. Circulation. 2024;150(2):151\u201361.","journal-title":"Circulation"},{"issue":"4","key":"6207_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","volume":"119","author":"CG Pham","year":"2004","unstructured":"Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119(4):529\u201342.","journal-title":"Cell"},{"issue":"2","key":"6207_CR20","doi-asserted-by":"publisher","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","volume":"11","author":"N Grote Beverborg","year":"2018","unstructured":"Grote Beverborg N, Klip IT, Meijers WC, Voors AA, Vegter EL, van der Wal HH, et al. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients. Circ Heart Fail. 2018;11(2):e004519.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"6207_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol. 2011;58(12):1241\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6207_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s12872-024-04368-y","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang H, Li Y, Zhou J, Wang J, Shao J, Yue S, et al. Impact of Intravenous Iron in patients with heart failure and Iron Deficiency: an updated Meta-analysis of Randomized controlled trials. BMC Cardiovasc Disord. 2024;24(1):695.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"6207_CR23","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1002\/ehf2.14849","volume":"11","author":"CC Cabrera","year":"2024","unstructured":"Cabrera CC, Ekstrom M, Tornvall P, Lofstrom U, Frisk C, Linde C, et al. Iron deficiency in new onset heart failure: association with clinical factors and quality of life. ESC Heart Fail. 2024;11(5):2661\u201371.","journal-title":"ESC Heart Fail"},{"issue":"2","key":"6207_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/ehf2.14999","volume":"12","author":"X Chen","year":"2025","unstructured":"Chen X, Pivodic A, Schaufelberger M, Rosengren A, Fu M. Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008\u20132017. ESC Heart Fail. 2025;12(2):832\u20138.","journal-title":"ESC Heart Fail"},{"key":"6207_CR25","unstructured":"Socialstyrelsen. Nationella riktlinjer f\u00f6r hj\u00e4rtsjukv\u00e5rd \u2013 St\u00f6d f\u00f6r styrning och ledning. Stockholm: Socialstyrelsen; 2018. Report No.: 2018-6-28."},{"key":"6207_CR26","doi-asserted-by":"crossref","unstructured":"Svensson S\u00f6derberg KKLL, Lindow T, et al. Heart failure in Southern Sweden (HISS): a cross-sectional analysis of primary care patients\u2019 characteristics and physicians\u2019 adherence to guideline-directed medical therapy. BMJ Open. 2025;15(11):e101178.","DOI":"10.1136\/bmjopen-2025-101178"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06207-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06207-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06207-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:33:07Z","timestamp":1783081987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06207-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6207"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06207-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (Dnr 2019-03944). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}